Literature DB >> 16515545

Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway.

Zhili Huang1, Qingsong Hou, Nam Sang Cheung, Qiu-Tian Li.   

Abstract

An elevated level of cholesterol in mitochondrial membranes of Niemann-Pick disease type C1 (NPC1) mouse brains and neural cells has been found to cause mitochondrial dysfunction. In this study, we demonstrate that inhibition of intracellular cholesterol trafficking in primary neurons by class 2 amphiphiles, which mimics the major biochemical and cellular feature of NPC1, led to not only impaired mitochondrial function but also activation of the mitochondrial apoptosis pathway. In activation of this pathway both cytochrome c and Smac/Diablo were released but apoptosis-inducing factor (AIF) was not involved. Treatment of the neurons with taurine, a caspase 9-specific inhibitor, could prevent the amphiphile-induced apoptotic cell death, suggesting that formation of apoptosome, followed by caspase 9 and caspase 3 activation, might play a critical role in the neuronal death pathway. Taken together, the mitochondria-dependent death cascade induced by blocking intracellular cholesterol trafficking was caspase dependent. The findings provide clues for both understanding the molecular basis of neurodegeneration in NPC1 disease and developing therapeutic strategies for treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515545     DOI: 10.1111/j.1471-4159.2006.03733.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases.

Authors:  Afshin Saffari; Stefan Kölker; Georg F Hoffmann; Darius Ebrahimi-Fakhari
Journal:  J Inherit Metab Dis       Date:  2017-05-05       Impact factor: 4.982

2.  Autophagy, mitochondria and cell death in lysosomal storage diseases.

Authors:  Kirill Kiselyov; John J Jennigs; Youssef Rbaibi; Charleen T Chu
Journal:  Autophagy       Date:  2007-05-23       Impact factor: 16.016

3.  Role of cathepsin D in U18666A-induced neuronal cell death: potential implication in Niemann-Pick type C disease pathogenesis.

Authors:  Asha Amritraj; Yanlin Wang; Timothy J Revett; David Vergote; David Westaway; Satyabrata Kar
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

Review 4.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

5.  Functional TauT protects against acute kidney injury.

Authors:  Xiaobin Han; Junming Yue; Russell W Chesney
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

6.  Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice.

Authors:  Asha Amritraj; Kyle Peake; Anitha Kodam; Chiara Salio; Adalberto Merighi; Jean E Vance; Satyabrata Kar
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

Review 7.  Mitochondrial Ca2+ homeostasis in lysosomal storage diseases.

Authors:  Kirill Kiselyov; Shmuel Muallem
Journal:  Cell Calcium       Date:  2008-02-01       Impact factor: 6.817

Review 8.  Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities.

Authors:  Linda Ingemann; Thomas Kirkegaard
Journal:  J Lipid Res       Date:  2014-05-16       Impact factor: 5.922

9.  Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures.

Authors:  José M Palanca; Diana Aguirre-Rueda; Manuel V Granell; Martin Aldasoro; Alma Garcia; Antonio Iradi; Elena Obrador; Maria Dolores Mauricio; Jose Vila; Anna Gil-Bisquert; Soraya L Valles
Journal:  Int J Med Sci       Date:  2013-08-03       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.